Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?

C. Tron (1) , C. Arnoult (1) , C. Leven (1) , P. Fillatre (2, 3, 4) , C. Pronier (1) , M. Revest (2, 4, 5) , M. C. Verdier (1) , E. Bellissant (2, 1) , F Lemaitre (1)

1 CHU Pontchaillou [Rennes]
2 CIC - Centre d'Investigation Clinique [Rennes]
3 Service de Pharmacologie [Rennes]
4 Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes]
5 Fonction, structure et inactivation d'ARN bactériens

Meeting Abstract: PM2-036, 20e congrès de la Société Française de Pharmacologie et de Thérapeutique, Nancy, 19-21 avril 2016

Domains: Life Sciences [q-bio]

C. Tron, C. Arnoult, C. Leven, P. Fillatre, C. Pronier, et al.. Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?. Fundamental & Clinical Pharmacology, 2016, 30, pp.43. ⟨hal-01310755⟩